7445-0110 Screening compound: 2-{[4-ethyl-5-(2-hydroxyphenyl)-4H-1,2,4-triazol-3-yl]sulfanyl}-N-[4-(4-methylphenyl)-1,3-thiazol-2-yl]acetamide

7445-0110 Screening compound: 2-{[4-ethyl-5-(2-hydroxyphenyl)-4H-1,2,4-triazol-3-yl]sulfanyl}-N-[4-(4-methylphenyl)-1,3-thiazol-2-yl]acetamide
7445-0110 Screening compound: 2-{[4-ethyl-5-(2-hydroxyphenyl)-4H-1,2,4-triazol-3-yl]sulfanyl}-N-[4-(4-methylphenyl)-1,3-thiazol-2-yl]acetamide alternative view

Chemical Structure Depiction of ChemDiv screening compound 7445-0110
2-{[4-ethyl-5-(2-hydroxyphenyl)-4H-1,2,4-triazol-3-yl]sulfanyl}-N-[4-(4-methylphenyl)-1,3-thiazol-2-yl]acetamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

7445-0110

Molecular Formula

C22H21N5O2S2 (C22 H21 N5 O2 S2)

Compound Name

2-{[4-ethyl-5-(2-hydroxyphenyl)-4H-1,2,4-triazol-3-yl]sulfanyl}-N-[4-(4-methylphenyl)-1,3-thiazol-2-yl]acetamide

IUPAC name

2-{[4-ethyl-5-(2-hydroxyphenyl)-4H-124-triazol-3-yl]sulfanyl}-N-[4-(4-methylphenyl)-13-thiazol-2-yl]acetamide

SMILES

CCn1c(SCC(Nc2nc(-c3ccc(C)cc3)cs2)=O)nnc1-c(cccc1)c1O

InChI

InChI=1S/C22H21N5O2S2/c1-3-27-20(16-6-4-5-7-18(16)28)25-26-22(27)31-13-19(29)24-21-23-17(12-30-21)15-10-8-14(2)9-11-15/h4-12,28H,3,13H2,1-2H3,(H,23,24,29)

InChI Key

NDTCSQAAJUOCJC-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD06008133

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

451.57

Hydrogen Bond Acceptors Count

7.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

8.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

5.787

Distribution Coefficient, logD

5.773

Water Solubility, LogSw

-5.18

Polar Surface Area

73.438

Acid Dissociation Constant (pKa)

8.87

Base Dissociation Constant (pKb)

4.30

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

18.20

7445-0110 in Drug Discovery

Included in Screening Libraries

CNS targets activity set (6557 compounds)

GABA Library (7115 compounds)

Human GPCR Annotated Library (5539 compounds)

Immunological Library (6760 compounds)

PPI Inhibitors Tripeptide Mimetics (23972 compounds)

Purinergic Library (3321 compounds)

SmartTM Library (51161 compounds)

ChemoGenomic Annotated Library for Phenotypic Screening (89798 compounds)

Epigenetics Focused Set (26518 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Eye
  • Immune system
  • Nervous system
  • Cardiovascular
  • Metabolic
Targets:
  • GPCR
  • Ion Channels
  • GPCR
  • Ion Channels
Mechanism of action:
  • Receptor's ligands
  • PPI modulators
  • Receptor's ligands
Structure:
  • Mimetics

References: we are preparing a list of scientific research reports with 7445-0110 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound 7445-0110?
Check Price and Availability of 7445-0110, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of 7445-0110 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for 7445-0110
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for 7445-0110
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of 7445-0110 available by request